RxDoctor Payments Data

Henry Hulter

Nephrology · San Rafael, CANPI 1104139633

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $401,311 of the $401,311 with a category attached, or 100.0%. GSK accounts for 90.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $363,561 and has fallen 99.9% since, to $500 in 2021. Among nephrology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$401,311in general payments, 2019–2025

Across 28 payments — averaging $14,333 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$364K
  • Coherus Oncology, Inc.$38K
$165,206in research payments, 2019–2025

Across 2 payments — averaging $82,603 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$165K

What the payments were for

  • Consulting fees$401,311100%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK19$363,561
Coherus Oncology, Inc.9$37,750

How this compares

$401,311 in reported general payments places this provider in the 95th percentile of 1,341 nephrology providers in California.

See all nephrology providers in California →

Other nephrology in San Rafael

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →